ArticleFrontiers in oncology2024

Cutaneous adverse events due to checkpoint inhibitors - a retrospective analysis at a tertiary referral hospital in Switzerland 2019-2022.

Clara Furrer-Matcau et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.